1981
DOI: 10.1016/0009-8981(81)90373-9
|View full text |Cite
|
Sign up to set email alerts
|

Urinary excretion of and alanine aminopeptidase in patients receiving amikacin or cis-platinum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0
1

Year Published

1983
1983
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 79 publications
(29 citation statements)
references
References 14 publications
0
28
0
1
Order By: Relevance
“…In patients treated with some antineoplastic agents, nephrotoxic side-effects are observed [2,3,6,8,9,12,14,15,19,30,32,33,35], The question is whether nephrotoxic effects occur in hospital workers who are occupationally ex posed to antineoplastic agents. Up to now, no such data have been published.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In patients treated with some antineoplastic agents, nephrotoxic side-effects are observed [2,3,6,8,9,12,14,15,19,30,32,33,35], The question is whether nephrotoxic effects occur in hospital workers who are occupationally ex posed to antineoplastic agents. Up to now, no such data have been published.…”
Section: Discussionmentioning
confidence: 99%
“…These parameters are widely used in occupational medicine for the detec tion of nephrotoxic effects in workers exposed to chem icals [16,35]. They are also applied clinically to control nephrotoxic side-effects of drugs such as aminoglyco sides [3] and antineoplastic agents like cisplatin [2,3,6,8,9,12,14,15,19,30,32,33,35].…”
Section: Introductionmentioning
confidence: 99%
“…Normal serum contains only one isoenzyme, while in liver, biliary or pancreatic disease additional fractions are found. The enzyme is found in urine [16].…”
Section: Markers For Assessment Of Renal Damagementioning
confidence: 99%
“…Unter Cisplatintherapie ist z. B. die Alaninaminopeptidase-Ausscheidung höher als die N-Acetyl-ß-Z>-glucosaminidase-Ausscheidung, wäh-rend sich dies bei Amikacin-Therapie umgekehrt verhält (13 (14). Erforderlich sind stets Angaben der diagnostischen Validitätskenngrößen Sensitivität, Spezifität, Effizienz.…”
Section: Nephrotoxizitätunclassified